Amended in Senate April 7, 2014

Senate BillNo. 830


Introduced by Senator Galgiani

January 6, 2014


An act to amendbegin delete Sectionend deletebegin insert Sectionsend insert 128745begin insert and 128748end insert of the Health and Safety Code, relating to health care.

LEGISLATIVE COUNSEL’S DIGEST

SB 830, as amended, Galgiani. Health care: health facility data.

Existing law establishes the Office of Statewide Health Planning and Development, which is vested with all the duties, powers, responsibilities, and jurisdiction of the State Department of Public Health relating to health planning and research development. Existing law requires the office to publish certain risk-adjusted outcomebegin delete reports.end deletebegin insert reports for specified medical, surgical, or obstetric conditions or procedures, including a coronary artery bypass graft surgery. Existing law requires the office to collect the same data used for the most recent risk-adjusted model, as specified, and authorizes the office to add any clinical data elements included in the Society of Thoracic Surgeons’ database. Prior to any additions from the Society of Thoracic Surgeons’ database, existing law sets forth factors the office is required to assess.end insertbegin insert Existing law authorizes the office to add, delete, or revise any clinical data elements not included in the Society of Thoracic Surgeons’ database, as specified.end insert

begin insert

This bill, commencing July 1, 2015, would additionally require the office to publish risk-adjusted outcome reports for all coronary artery bypass graft and heart valve repair and replacement surgeries, and all percutaneous cardiac interventions and transcatheter valve procedures performed in the state, as specified. The bill would remove the office’s authorization to add, delete, or revise clinical data elements not included in the Society of Thoracic Surgeons’ database, would authorize the office to add any clinical data elements included in the National Cardiovascular Data Registry CATH/PCI and TAVR databases with regard to the reports for percutaneous cardiac interventions and transcatheter valve procedures, and would revise the factors to be considered before the office adds clinical data elements.

end insert
begin insert

Existing law requires the Director of the Office of Statewide Planning and Development to appoint, as specified, a 9-member clinical panel for each risk-adjusted outcome report on a medical, surgical, or obstetric condition or procedure that includes reporting data of an individual physician, including coronary artery bypass graft surgery. For the clinical panel authorized for coronary artery bypass graft surgery, existing law requires 3 members to be appointed from a list of names submitted by the California Medical Association.

end insert
begin insert

This bill would instead require the office director to appoint 3 members from a list of 3 or more names submitted by the California Society of Thoracic Surgeons and would additionally require that one appointee be an interventionalist and a member of the Society of Angiography for a clinical panel authorized for coronary artery bypass surgery and heart valve repair and replacement surgery. The bill would additionally require the office director to appoint specified individuals, including, among others, 3 members from a list of names submitted by the California Chapter of the American College of Cardiology, to a clinical panel authorized for percutaneous cardiac interventions and transcatheter valve procedures.

end insert
begin insert

The bill would require all heart valve repair and replacement transcatheter interventions or surgery procedures to be reviewed by a joint subpanel of the coronary artery bypass graft surgery and heart valve repair and replacement surgery, and percutaneous cardiac intervention clinical panels, as provided.

end insert
begin delete

This bill, commencing July 1, 2015, would require the office to publish risk-adjusted outcome reports for percutaneous coronary interventions, including the use of angioplasty or stents, and transcatheter valve procedures.

end delete

Vote: majority. Appropriation: no. Fiscal committee: yes. State-mandated local program: no.

The people of the State of California do enact as follows:

P3    1

SECTION 1.  

Section 128745 of the Health and Safety Code
2 is amended to read:

3

128745.  

(a) Commencing July 1993, and annually thereafter,
4the office shall publish risk-adjusted outcome reports in accordance
5with the following schedule:


6

 

  

Procedures and

Publication

Period

Conditions

  Date  

Covered

Covered

July 1993

1988-90

3

July 1994

1989-91

6

July 1995

1990-92

9

P3   13

 

14Reports for subsequent years shall include conditions and
15procedures and cover periods as appropriate.

16(b) The procedures and conditions required to be reported under
17this chapter shall be divided among medical, surgical, and obstetric
18conditions or procedures and shall be selected by the office. The
19office shall publish the risk-adjusted outcome reports for surgical
20 procedures by individual hospital and individual surgeon unless
21the office in consultation with medical specialists in the relevant
22area of practice determines that it is not appropriate to report by
23individual surgeon. The office, in consultation with the clinical
24panel established by Section 128748 and medical specialists in the
25relevant area of practice, may decide to report nonsurgical
26procedures and conditions by individual physician when it is
27appropriate. The selections shall be in accordance with all of the
28following criteria:

29(1) The patient discharge abstract contains sufficient data to
30undertake a valid risk adjustment. The risk adjustment report shall
31ensure that public hospitals and other hospitals serving primarily
32low-income patients are not unfairly discriminated against.

33(2) The relative importance of the procedure and condition in
34terms of the cost of cases and the number of cases and the
35seriousness of the health consequences of the procedure or
36condition.

37(3) Ability to measure outcome and the likelihood that care
38influences outcome.

P4    1(4) Reliability of the diagnostic and procedure data.

2(c) (1) In addition to any other established and pending reports,
3on or before July 1, 2002, the office shall publish a risk-adjusted
4outcome report for coronary artery bypass graft surgery by hospital
5for all hospitals opting to participate in the report. This report shall
6be updated on or before July 1, 2003.

7(2) In addition to any other established and pending reports,
8commencing July 1, 2004, and every year thereafter, the office
9shall publish risk-adjusted outcome reports for coronary artery
10bypass graft surgery for all coronary artery bypass graft surgeries
11performed in the state. In each year, the reports shall compare
12risk-adjusted outcomes by hospital, and in every other year, by
13hospital and cardiac surgeon. Upon the recommendation of the
14clinicalbegin delete panelend deletebegin insert panelsend insert established by Section 128748 based on
15statistical and technical considerations, information on individual
16hospitals and surgeons may be excluded from the reports.

begin insert

17(3) In addition to any other established and pending reports,
18commencing July 1, 2015, and every year thereafter, the office
19shall publish risk-adjusted outcome reports for coronary artery
20bypass graft surgery and heart valve repair and replacement
21surgery for all coronary artery bypass graft surgeries and heart
22valve repair and replacement surgeries performed in the state. In
23each year, the reports shall compare risk-adjusted outcomes by
24hospital, and in every other year, by hospital and cardiac surgeon.
25Upon the recommendation of the clinical panels established
26pursuant to Section 128748 based on statistical and technical
27considerations, information on individual hospitals and surgeons
28may be excluded from the reports.

end insert
begin delete

29(3)

end delete

30begin insert(end insertbegin insert4)end insert Unless otherwise recommended by the clinicalbegin delete panelend deletebegin insert panelsend insert
31 established bybegin insert subdivision (d) ofend insert Section 128748, the office shall
32collect the same data used for the most recent risk-adjusted model
33developed for the California Coronary Artery Bypass Graft
34Mortality Reporting Program. Upon recommendation of the clinical
35panel, the office may add any clinical data elements included in
36the Society of Thoracic Surgeons’ database. Prior to any additions
37from the Society of Thoracic Surgeons’ database, thebegin delete following
38factors shall be considered:end delete
begin insert office shall consider the utilization of
39sampling to the maximum extent possible.end insert

begin delete

40(A) Utilization of sampling to the maximum extent possible.

end delete
begin delete

P5    1(B) Exchange of data elements as opposed to addition of data
2elements.

end delete
begin delete

3(4) Upon recommendation of the clinical panel, the office may
4add, delete, or revise clinical data elements, but shall add no more
5than a net of six elements not included in the Society of Thoracic
6Surgeons’ database, to the data set over any five-year period. Prior
7to any additions or deletions, all of the following factors shall be
8considered:

end delete
begin delete

9(A) Utilization of sampling to the maximum extent possible.

end delete
begin delete

10(B) Feasibility of collecting data elements.

end delete
begin delete

11(C) Costs and benefits of collection and submission of data.

end delete
begin delete

12(D) Exchange of data elements as opposed to addition of data
13elements.

end delete

14(5) The office shall collect the minimum data necessary for
15purposes of testing or validating a risk-adjusted model for the
16coronary artery bypass graftbegin insert and heart valve repair and
17replacementend insert
report.

18(6) Patient medical record numbers and any other data elements
19that the office believes could be used to determine the identity of
20an individual patient shall be exempt from the disclosure
21requirements of the California Public Records Act (Chapter 3.5
22(commencing with Section 6250) of Division 7 of Title 1 of the
23Government Code).

begin delete

24(d) In addition to any other established and pending reports,
25commencing July 1, 2015, and every year thereafter, the office
26shall publish risk-adjusted outcome reports for percutaneous
27coronary interventions, including, but not limited to, the use of
28angioplasty or stents, and transcatheter valve procedures.

end delete
begin insert

29(d) In addition to any other established and pending reports,
30commencing July 1, 2015, and every year thereafter, the office
31shall publish risk-adjusted outcome reports for percutaneous
32cardiac intervention and transcatheter valve procedure for all
33percutaneous cardiac intervention and transcatheter valve
34procedures performed in the state. In each year, the reports shall
35compare risk-adjusted outcomes by hospital, and in every other
36year, by hospital and physician. Upon the recommendation of the
37clinical panel established by Section 128748 based on statistical
38and technical considerations, information on individual hospitals
39and physicians may be excluded from the reports.

end insert
begin insert

P6    1(1) The office shall collect the same data used for the National
2Cardiovascular Data Registry Cath/PCI and TAVR databases.
3Upon recommendation of the clinical panel, the office may add
4any clinical data elements included in the National Cardiovascular
5Data Registry Cath/PCI and TAVR databases. Prior to any
6additions from the National Cardiovascular Data Registry
7Cath/PCI and TAVR databases, the office shall consider the
8utilization of sampling to the maximum extent possible.

end insert
begin insert

9(2) The office shall collect the minimum data necessary for
10purposes of testing or validating a risk-adjusted model for the
11percutaneous cardiac intervention and transcatheter valve
12procedure report.

end insert
begin insert

13(3) Patient medical record numbers and any other data elements
14that the office believes could be used to determine the identity of
15an individual patient shall be exempt from the disclosure
16requirements of the California Public Records Act (Chapter 3.5
17(commencing with Section 6250) of Division 7 of Title 1 of the
18Government Code).

end insert

19(e) The annual reports shall compare the risk-adjusted outcomes
20experienced by all patients treated for the selected conditions and
21procedures in each California hospital during the period covered
22by eachbegin delete report,end deletebegin insert reportend insert to the outcomes expected. Outcomes shall
23be reported in the five following groupings for each hospital:

24(1) “Much higher than average outcomes,” for hospitals with
25risk-adjusted outcomes much higher than the norm.

26(2) “Higher than average outcomes,” for hospitals with
27risk-adjusted outcomes higher than the norm.

28(3) “Average outcomes,” for hospitals with average risk-adjusted
29outcomes.

30(4) “Lower than average outcomes,” for hospitals with
31risk-adjusted outcomes lower than the norm.

32(5) “Much lower than average outcomes,” for hospitals with
33risk-adjusted outcomes much lower than the norm.

34(f) For coronary artery bypass graft surgery reports and any
35other outcome reports for which auditing is appropriate, the office
36shall conduct periodic auditing of data at hospitals.

37(g) The office shall publish in the annual reports required under
38this section the risk-adjusted mortality rate for each hospital and
39for those reports that include physician reporting, for each
40physician.

P7    1(h) The office shall either include in the annual reports required
2under this section, or make separately available at cost to any
3person requesting it, risk-adjusted outcomes data assessing the
4statistical significance of hospital or physician data at each of the
5following three levels: 99-percent confidence level (0.01 p-value),
695-percent confidence level (0.05 p-value), and 90-percent
7confidence level (0.10 p-value). The office shall include any other
8analysis or comparisons of the data in the annual reports required
9under this section that the office deems appropriate to further the
10purposes of this chapter.

11begin insert

begin insertSEC. 2.end insert  

end insert

begin insertSection 128748 of the end insertbegin insertHealth and Safety Codeend insertbegin insert is
12amended to read:end insert

13

128748.  

(a)  This section shall apply to any risk-adjusted
14outcome report that includes reporting of data by an individual
15physician.

16(b)  (1)  The office shall obtain data necessary to complete a
17risk-adjusted outcome report from hospitals. If necessary data for
18an outcome report is available only from the office of a physician
19and not the hospital where the patient received treatment, then the
20hospital shall make a reasonable effort to obtain the data from the
21physician’s office and provide the data to the office. In the event
22that the office finds any errors, omissions, discrepancies, or other
23problems with submitted data, the office shall contact either the
24hospital or physician’s office that maintains the data to resolve the
25problems.

26(2)  The office shall collect the minimum data necessary for
27purposes of testing or validating a risk-adjusted model. Except for
28data collected for purposes of testing or validating a risk-adjusted
29model, the office shall not collect data for an outcome report nor
30issue an outcome report until the clinical panel established pursuant
31to this section has approved the risk-adjusted model.

32(c)  For each risk-adjusted outcome report on a medical, surgical,
33or obstetric condition or procedure that includes reporting of data
34by an individual physician, the office director shall appoint a
35clinical panel, which shall have nine members. Three members
36shall be appointed from a list of three or more names submitted
37by the physician specialty society that most represents physicians
38performing the medical, surgical, and obstetric procedure for which
39data is collected. Three members shall be appointed from a list of
40three or more names submitted by the California Medical
P8    1Association. Three members shall be appointed from lists of names
2submitted by consumer organizations. At least one-half of the
3appointees from the lists submitted by the physician specialty
4society and the California Medical Association, and at least one
5appointee from the lists submitted by consumer organizations,
6shall be experts in collecting and reporting outcome measurements
7for physicians or hospitals. The panel may include physicians from
8another state. The panel shall review and approve the development
9of the risk-adjustment model to be used in preparation of the
10outcome report.

11(d)  For the clinical panel authorized by subdivision (c) for
12coronary artery bypass graft surgerybegin insert and heart valve repair and
13replacement surgeryend insert
, three members shall be appointed from a list
14of three or more names submitted by the California Chapter of the
15American College of Cardiology. Three members shall be
16appointed frombegin insert aend insert list of three or more names submitted by the
17Californiabegin delete Medical Associationend deletebegin insert Society of Thoracic Surgeonsend insert.
18Three members shall be appointed from lists of names submitted
19by consumer organizations. At least one-half of the appointees
20from the lists submitted by the California Chapter of the American
21College ofbegin delete Cardiology,end deletebegin insert Cardiologyend insert and the Californiabegin delete Medical
22Associationend delete
begin insert Society of Thoracic Surgeonsend insert, and at least one
23appointee from the lists submitted by consumer organizations,
24shall be experts in collecting and reporting outcome measurements
25for physicians and surgeons or hospitalsbegin insert, and one appointee shall
26be an interventionalist and member of the Society of Angiography
27and Interventionend insert
. The panel may include physicians from another
28state. The panel shall review and approve the development of the
29risk-adjustment model to be used in preparation of the outcome
30report.

begin insert

31(e) For the clinical panel authorized by subdivision (c) for
32percutaneous cardiac interventions and transcatheter valve
33procedures, three members shall be appointed from a list of three
34or more names submitted by the California Chapter of the
35American College of Cardiology. Three members shall be
36appointed from a list of three or more names submitted by the
37California Medical Association. Three members shall be appointed
38from lists of names submitted by consumer organizations. At least
39one-half of the appointees from the lists submitted by the California
40Chapter of the American College of Cardiology and the California
P9    1Medical Association, and at least one appointee from the lists
2submitted by consumer organizations, shall be experts in collecting
3and reporting outcome measurements for physicians and surgeons
4or hospitals, and one appointee shall be a cardiovascular surgeon
5and a member of the California Society of Thoracic Surgery. The
6panel may include physicians from another state. The panel shall
7review and approve the development of the risk-adjustment model
8to be used in preparation of the outcome report.

end insert
begin insert

9(f) All heart valve repair and replacement transcatheter
10interventions or surgery procedures shall also be reviewed by a
11joint subpanel of the coronary artery bypass graft surgery and
12heart valve repair and replacement surgery and percutaneous
13cardiac intervention panels. The subpanel shall be comprised of
14three members appointed from the clinical panel established in
15subdivision (d), three members appointed from the panel
16established in subdivisions (e), and shall be chaired by one member
17of the office. The subpanel may make recommendations to the
18panels established in subdivisions (d) and (e) relating to valve
19repair and replacement transcatheter interventions or surgery
20procedures.

end insert
begin delete

21(e)

end delete

22begin insert(end insertbegin insertg) end insert Any report that includes reporting by an individual physician
23shall include, at a minimum, the risk-adjusted outcome data for
24each physician. The office may also include in the report, after
25consultation with the clinical panel, any explanatory material,
26comparisons, groupings, and other information to facilitate
27consumer comprehension of the data.

begin delete

28(f)

end delete

29begin insert(end insertbegin inserth) end insert Members of a clinical panel shall serve without
30compensation, but shall be reimbursed for any actual and necessary
31expenses incurred in connection with their duties as members of
32the clinical panel.



O

    98